EU HTA Regulation: Companies Want Bigger Role In Shaping Assessments
A bigger role for companies in the scoping process for the imminent EU-level joint clinical assessments is essential for patient access, according to industry.
You may also be interested in...
A report published by the European Medicines Agency highlights milestones reached under its collaboration with EUnetHTA over recent years and outlines areas for further development once the initiative changes hands under the new HTA Regulation.
Legal and industry expert Alexander Natz sets out key questions and answers to help companies prepare for new EU regulations on health technology assessments, one of the biggest developments to affect the pharmaceutical industry in over a decade.
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.